Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
State Street Corporation’s subsidiary has ceased to be a substantial holder in Australian Clinical Labs Ltd as of October 21, 2024. This change in holding could influence investor perspectives on the company’s stock performance in the market. The shift highlights dynamic movements within the financial holdings of large corporations.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.